164 related articles for article (PubMed ID: 32672896)
1. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.
Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA
Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients.
Damlaj M; Alahmari B; Alaskar A; Alhejazi A; Alsadi H; Ahmed M; Alanazi T; Ahmed R; Alharbi A; Shehabeddine I; Alzaidi A; Alkhuraisat S; Mahassnah I; Alquraan H; Ballili M; Alzahrani M
Am J Hematol; 2024 Jun; 99(6):1023-1030. PubMed ID: 38488686
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
Inam Z; Tisdale JF; Leonard A
Expert Rev Hematol; 2023; 16(11):879-903. PubMed ID: 37800996
[TBL] [Abstract][Full Text] [Related]
4. Ovarian tissue cryopreservation for fertility preservation before hematopoietic stem cell transplantation in patients with sickle cell disease: safety, ovarian function follow-up, and results of ovarian tissue transplantation.
Missontsa MM; Bernaudin F; Fortin A; Dhédin N; Pondarré C; Yakouben K; Neven B; Castelle M; Cavazzana M; Lezeau H; Peycelon M; Paye-Jaouen A; Sroussi J; Diesch-Furlanetto T; Barraud-Lange V; Sarnacki S; Fahd M; Marchand I; Delcour C; Vexiau D; Arlet JB; Kamdem A; Arnaud C; Dalle JH; Poirot C
J Assist Reprod Genet; 2024 Apr; 41(4):1027-1034. PubMed ID: 38358434
[TBL] [Abstract][Full Text] [Related]
5. Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease.
Leonard A; Furstenau D; Abraham A; Darbari DS; Nickel RS; Limerick E; Fitzhugh C; Hsieh M; Tisdale JF
Blood Adv; 2023 Jan; 7(2):227-234. PubMed ID: 36240296
[TBL] [Abstract][Full Text] [Related]
6. Potential Risk Factors Associated With Graft Failure of Haploidentical Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Disease.
Yu J; Black V; Lamba J; Horn B
J Pediatr Hematol Oncol; 2021 May; 43(4):e583-e586. PubMed ID: 32604335
[TBL] [Abstract][Full Text] [Related]
7. Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis.
Dovern E; Aydin M; DeBaun MR; Alizade K; Biemond BJ; Nur E
Am J Hematol; 2024 Jun; 99(6):1129-1141. PubMed ID: 38517255
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Huang B; Shan J; Yi L; Xin Y; Zhong Z; Xu H
Pediatr Nephrol; 2024 Feb; 39(2):397-408. PubMed ID: 37079103
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: A Multidimentional Review.
Rostami T; Rad S; Rostami MR; Mirhosseini SA; Alemi H; Khavandgar N; Janbabai G; Kiumarsi A; Kasaeian A; Mousavi SA
Cell Transplant; 2024; 33():9636897241246351. PubMed ID: 38680015
[TBL] [Abstract][Full Text] [Related]
10. [Follow-up analysis of sex hormone levels and prognosis in women after hematopoietic stem cell transplantation].
Xu QW; Du YY; Lyu KK; Xu MM; Gu CY; Kang HZ; Feng SL; Liu YJ; Wu DP; Han Y
Zhonghua Nei Ke Za Zhi; 2023 Nov; 62(11):1303-1310. PubMed ID: 37935496
[No Abstract] [Full Text] [Related]
11. Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review.
Greenberg JH; Coca S; Parikh CR
BMC Nephrol; 2014 Nov; 15():184. PubMed ID: 25416588
[TBL] [Abstract][Full Text] [Related]
12. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases.
Nelson AS; Vajdic CM; Ashton LJ; Le Marsney RE; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
Pediatr Blood Cancer; 2017 Jan; 64(1):197-202. PubMed ID: 27671369
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia.
Lucarelli G; Isgrò A; Sodani P; Gaziev J
Cold Spring Harb Perspect Med; 2012 May; 2(5):a011825. PubMed ID: 22553502
[TBL] [Abstract][Full Text] [Related]
14. Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?
Flor-Park MV; Ozahata MC; Moura ICG; Blatyta P; Kelly S; Oliveira CDL; Capuani L; Belisário AR; Carneiro-Proietti ABF; Araujo AS; Loureiro P; Maximo C; Rodrigues DOW; Mota RA; Sabino E; Custer B; Rocha V;
Transplant Cell Ther; 2022 Oct; 28(10):708.e1-708.e8. PubMed ID: 35788087
[TBL] [Abstract][Full Text] [Related]
15. Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease.
Hulbert ML; Fields ME; Guilliams KP; Bijlani P; Shenoy S; Fellah S; Towerman AS; Binkley MM; McKinstry RC; Shimony JS; Chen Y; Eldeniz C; Ragan DK; Vo K; An H; Lee JM; Ford AL
Blood; 2023 Jan; 141(4):335-344. PubMed ID: 36040484
[TBL] [Abstract][Full Text] [Related]
16. Dermatologic complications in pediatric patients after hematopoietic stem cell transplantation for sickle cell disease.
Dignum T; Burroughs L; Mallhi K; Brandling-Bennett HA
Pediatr Dermatol; 2024; 41(1):61-65. PubMed ID: 37965881
[TBL] [Abstract][Full Text] [Related]
17. In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation.
Leonard AK; Furstenau D; Inam Z; Luckett C; Chu R; Demirci S; Essawi K; Gudmundsdottir B; Hinds M; DiNicola J; Li Q; Eaton WA; Cellmer T; Wang X; Thein SL; Macari ER; VanNest S; Hsieh MM; Bonner M; Pierciey FJ; Tisdale JF
Blood Adv; 2024 Apr; 8(7):1806-1816. PubMed ID: 38181784
[TBL] [Abstract][Full Text] [Related]
18. Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease.
Aumann MA; Richerson W; Song AK; Davis LT; Pruthi S; Davis S; Patel NJ; Custer C; Kassim AA; DeBaun MR; Donahue MJ; Jordan LC
Blood Adv; 2024 Feb; 8(3):608-619. PubMed ID: 37883803
[TBL] [Abstract][Full Text] [Related]
19. Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT).
Guffon N; Pettazzoni M; Pangaud N; Garin C; Lina-Granade G; Plault C; Mottolese C; Froissart R; Fouilhoux A
Orphanet J Rare Dis; 2021 Jan; 16(1):60. PubMed ID: 33517895
[TBL] [Abstract][Full Text] [Related]
20. Non-myeloablative allogeneic HSCT in adult patients with sickle cell disease: Multiple take-home points from the Saudi Arabia experience.
Rondelli D
Am J Hematol; 2024 Jun; 99(6):1021-1022. PubMed ID: 38606977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
